TRV GP IV, LLC — Q1 2025 13F-HR

← TRV GP IV, LLC

Q1 2025 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2025-05-09 · accession 0000950123-25-004486

$92.9M

Reported value

Positions

2025-03-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
578784100	MAZE	MAZE THERAPEUTICS, INC.	$66.9M	72.0%	6,073,958	Common	SOLE
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$23.1M	24.9%	16,859,075	Common	SOLE
729139105	PLRX	PLIANT THERAPEUTICS, INC.	$2.9M	3.10%	2,132,867	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.